Director
Training
Graduated "Summa cum Laude" on 18.10.1985 (experimental thesis on the "Activity of a new Macrolide on respiratory pathogens").
Postgraduate course on Tropical Medicine (CUAMM, Padova, 1986-7)
Speciality in Respiratory Medicine (1989) and Medical Statistics (1995).
Auditor Quality System UNI EN ISO 9002 (Certificate N°256, 13.4.1999)
Professional activities
May 1987 - August 1989: responsible, with the framework of the Health Cooperation Project of the Italian Ministry of Foreign Affairs, of the Tuberculosis (TB) and AIDS Control Programmes in Arua District, West Nile, Northern Uganda (the Programme implemented the TB control at Regional level, and the recording and reporting system for epidemiological and health planning purposes as a part of the new Ugandan National Health Information System).
Since October 1989: Consultant Chest Physician at the Department of Pneumonology, Fondazione Salvatore Maugeri, Care and Research Institute, Tradate, Italy, in charge of the Cell Biology Laboratory and of the Clinical Trials within the framework of GCP.
Since 1995: Consultant of the World Health Organization (in charge of TB control activities in Russia, Romania, Ukraine, Moldova, Turkey, Kossovo, Estonia and Mozambique). He was involved in TB Control in prisons in Ivanovo Oblast and Romania, in cost-effectiveness evaluation in Russia, Italy and Estonia.
Since October 2000, Director of the WHO Collaborating Centre for Tuberculosis and Lung Diseases and since July 2003 Head of the Clinical Epidemiology Service of Respiratory Disease, Fondazione Salvatore Maugeri, Care & Research Institute, Tradate, Italy
Since May 2001: consultant for the European Community in Ukraine (TACIS programme)
Since June 2001 member of the National Committee for TB control, MoH, Italy
From 2001 to 2004: Chairman “Tuberculosis” Study Group, AIPO (Italian Society of Hospital Pneumonologists)
Since 2000: Secretary General, IUATLD Europe Region
Since 2004: Collaboration with GFATM (alternate member TRP), consultant LFA (KPMG)
Since 2004: Scentific Advisor, StopTB Italy
Since 2005: Member TB Committee, Italian CCM (CDC)
Research Activities
1987-1989: research project on TB diagnosis in pediatrics, TB control, and AIDS/TB related infections in Uganda
He is presently coordinating several national and international research projects in the field of TB and asthma control for the Italian Ministry of Health, the World Health Organization and the IUATLD (International Union Against Tuberculosis and Lung Disease).
Since 1998 coordinator of the surveillance project for drug resistance in tuberculosis (Ministry of Health, Rome, Italy)
Since 1990 investigator in clinical trials (Asthma and COPD) within GCP.
Since 2002: member of the PPM and TB/HIV study groups, WHO DOTS Expansion Group, Geneva
Since 2003: member of the TAG (Technical Advisory Group), WHO Euro, Copenhagen
Since 2004: member of the International Steering Committee, Universal Standards of Care
Teaching activities
1987-1989: Lecturer on epidemiology of infectious diseases at the Arua Nursery and Midwifery school.
since 1995: Lecturer at the School of Specialization in Medical Statistics, University of Pavia.
since 1995: Lecturer of the IUATLD Post-Graduate Courses
since 1998: Lecturer at the WHO Course for TB managers, Warsaw (Poland)
since 1999: Lecturer of the European School of Respiratory Medicine (ERS, European Respiratory Society)
1999-2000: Lecturer at the School of Rehabilitation Therapists, University of Insubria, Varese
since 2001: Course Director, WHO Training Course for TB Consultants and Managers, Sondalo, Italy (15 Courses done till now in Italy, Russia and Ethiopia)
Scientific Societies
member of ERS (Study group on Tuberculosis), AIPO (Italian Society of Hospital Pneumonologists) and SIMET (Italian Society of Tropical Medicine).
AIPO: Study group "Tuberculosis " (that recently published a global TB control programme suitable for Italy).
ERS: chair study group "Tuberculosis" IUATLD: Secretary General of Europe Region.
Member of the Scientific Committee of the Wolfheze IUATLD/WHO Workshops on TB control in low prevalence countries
Member of the Advisory Board of Federazione Italiana contro la TB e le Malattie Polmonari Sociali.
Publications
Author of the European Guidelines for tuberculosis control and co-author of the main guidelines on TB control resulting from the IUATLD/WHO workshops (Wolfheze documents).
Author of WHO guide for training on TB/HIV collaborative activities.
Author of more than 200 scientific publications (original articles, reports, communications, editorials and book chapters, the main part of them published in Index Medicus/Science Citation Index indexed journals) on TB and pulmonary diseases.
Reviewer and section editor of national (Rass Pat App Resp) and international journals (Eur Respir J, Tuberc Lung Dis, In J Tuberc Lung Dis, Eur J Epidemiol, Respiration, Monaldi Arch Chest Dis, EID).
Languages
English and French: fluent.
Main publications, 2000-2005
Ferrara G, Richeldi L, Migliori GB et al. Management of multidrug resistant tuberculosis in Italy. Int J Tuberc Lung Dis 2005; 9,5:507-513.
Codecasa LR, Ferrarese M, Migliori GB et al. Comparison of Tuberculin Skin test and Quantiferon immunological assay for Latent Tuberculosis Infection. Monaldi Arch Chest Dis 2005; 63, 3 (in press)
Giannoni F, Iona E, Migliori GB et al. Evaluation of a new line probe assay for rapid identification of gyrA mutations in Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy 2005; 49,7: 2828-33.
Migliori GB, Centis R, Fattorini L, et al. Prevalence of Mycobacterium tuberculosis complex drug resistance in Italy: report of the SMIRA Study Group (1998-2001). Emerging Infectious Diseases, 2004; 10(4): 752-753
World Health Organization (Migliori GB as member of the Working Group). Anti-tuberculosis drug resistance in the world. Third global report. The WHO/IUATLD Global project on Anti-Tuberculosis Drug Resistance Surveillance. Geneva, 2004, WHO/HTM/TB/2004.300:1-300.
de Colombani P, Banatvala N, Zaleskis R, Maher D, Migliori GB (member of the review panel). European framework to decrease the burden of TB/HIV. Eur Respir J 2004; 24 :493-501
Codecasa LR, Ferrarese M, Migliori GB et al. Safety and tolerability to long term moxifloxacin treatment in 38 patients with difficult to manage tuberculosis: preliminary data. Eur Respir J 2004; 24 (48): 723s
Richeldi L, Floyd K, Migliori GB, et al. The cost of managing multidrug-resistant tuberculosis in an illegal immigrant in Italy. Eur Respir J 2004; 24 (48): 703s
Ferrara G, Codecasa LR, Richeldi L, Migliori GB et al. Differences among multidrug resistant tuberculosis patients in two metropolitan areas. Eur Respir J 2004; 24 (48): 439s
Chiotan D, Stoicescu P, Migliori GB et al. DOT versus self administration in TB treatment in pilot area of sector 4, Bucharest - 3 years early re-treatment analysis. Eur Respir J 2004; 24 (48): 362s
Codecasa LR, Migliori GB et al. Epidemiology and Control of Tuberculosis in Western European Cities. Int J Tuberc Lung Dis 2004; 8(10): 1275-6
Chiotan D, Migliori GB et al. 2 years and half experience in pilot project for DOTS implementation, Sector IV, Bucharest (Romania). Eur Respir J 2003; 22, 45: 521s.
Tarevici Z, Centis R, Migliori GB et al. Cost-effectiveness of the DOTS strategy of tuberculosis control in Iasi County, Romania. Eur Respir J 2003; 22, 45: 39s.
Fattorini L, Iona E. Migliori GB et al. Gyrase mutations in Fluoroquinolone- resistent clinical isolates of Mycobacterium tuberculosis isolated in Italy and Abkhazia. 103° General Meeting of the American Society for Microbiology (2003), 647-648.
Chiotan D, Ditiu L, Migliori GB et al. Drug resistance surveillance in Romania, 2003-2004: preparatory phase for implementation. Int J Tuberc Lung Dis 2003; 11: S219.
Migliori G.B., Centis R., Raviglione M.C. World wide distribution of Tuberculosis in 2002: short term perspectives. Epidemiologia & Prevenzione 2003; 27: 106-113.
Adherence to long term therapies : evidence for action. Report. Noncommunicable Diseases and Mental Health Adherence to Long Term Therapies project. World Health Organization 2003 (GB Migliori, member of the Global adherence Network).
de Colombani P., Banatvala N., Zaleskis R. et al (Migliori G.B., member of the review panel). European Framework to Decreases the Burden of TB/HIV published by WHO Regional Office for Europe, 2003 (ISBN 92 890 1089 4) http://www.euro.who.int/document/E81794.pdf.
Migliori GB, Centis R, Fattorini L et al. Monitoring the quality of laboratories and the prevalence of resistance: Italy 1998-2000; Eur Respir J 2003;21:1-6
Centis R, Migliori GB. Evaluation of tuberculosis treatment results in Italy, report 1999. Monaldi Arch Chest Dis 2002; 57:297-305.
Migliori GB, Centis R. Problems to control TB in Eastern Europe and consequences in low incidence countries. Monaldi Arch Chest Dis 2002; 57:285-290.
Migliori GB, Espinal M, Danilova ID et al. Frequency of recurrence among MDR-TB cases ‘successfully’ treated with standardised short-course chemotherapy. Int J Tuberc Lung Dis 2002; 6(10):858-864.
Broekmans JF, Migliori GB, Rieder HL et al. European framework for tuberculosis control and elimination in countries with a low incidence. Eur Respir J 2002; 19:765-775.
Migliori GB, Fattorini L, Vaccarino P et al. Prevalence of resistance to antituberculosis drugs: results of the 1998/99 national survey in Italy. Int J Tuberc Lung Dis 2002; 6(1): 32-38.
Fattorini L, Iona E, Migliori GB et al. Activity of 11 antimicrobial agents against multidrug-resistant strains of Mycobacterium tuberculosis isolated during the 1998/1999 National Survey in Italy. Clinical Microbiology and Infection 2002; 8, S1:95
Espinal MA, Migliori GB et al: Standard short course chemotherapy for drug-resistant tuberculosis. Treatment outcomes in 6 countries. JAMA 2000; 283:2537-2545.
Migliori GB, Ambrosetti M, Fattorini L et al. Surveillance of anti-tuberculosis drug resistance: results of the 1998-1999 proficiency testing in Italy. Int J Tuberc Lung Dis 2000; 4 (1): 1-7.
Spanevello A, Migliori GB et al. Induced sputum cellularity. Reference values and distribution in normal volunteers. Am J Respir Crit care Med 2000;162:1172-1174
Centis R, Ianni A & Migliori GB. Evaluation of tuberculosis treatment results in Italy, report 1998. Monaldi Arch Chest Dis 2000, 55, 4:293-298.
Migliori GB et al. Microbiological confirmation of tuberculosis cases at diagnosis and at the end of treatment in Italy. Eur J Epidemiol 2000;16:719-724.
Migliori GB (as member of the writing committee). American Thoracic Society, Centers for Disease Control and Prevention. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000;161,4: S221-S247.
Schwoebel V et al (Migliori GB as part of the Working Group). Standardization of antituberculosis drug resistance surveillance in Europe. Eur Respir J 2000;16:364-371.
World Health Organization, Communicable Diseases (Migliori GB as member of the Working Group). The WHO/IUATLD Global project on Anti-Tuberculosis Drug Resistance Surveillance. Report N°2, Prevalence and Trends. Geneva,2000,WHO/CDS/TB/2000.278:1-253.